Trade Mark Journal No.2026/045 6 November 2026
UK00004463487 21 October 2026 (5,42)
AMPMAB
- Class 5
- Biological preparations for the treatment of cancer; pharmaceuticals for the treatment of cancer; pharmaceutical preparations and substances for the prevention and treatment of cancer; antibody-based pharmaceutical preparations for the prevention and treatment of cancer; monoclonal antibodies for medical purposes; therapeutic antibodies for the treatment of cancer; antibody-drug conjugates for the treatment of cancer; antibody-oligonucleotide conjugates for the treatment of cancer; pharmaceutical preparations comprising antibodies conjugated to therapeutic payloads for the treatment of cancer; pharmaceutical preparations for the targeted intracellular delivery of therapeutic agents to cancer cells.
- Class 42
- Scientific research for medical purposes in the area of cancerous diseases; research and testing of pharmaceuticals for the treatment of cancer; drug discovery services in the area of cancerous diseases; scientific and technological research relating to the discovery and development of pharmaceuticals and therapeutic preparations; pharmaceutical research and development services; research and development of antibody-based therapeutics, monoclonal antibodies, antibody-drug conjugates and antibody-oligonucleotide conjugates; research and development relating to antibodies conjugated to therapeutic payloads, including small molecules and oligonucleotides; identification, screening and validation of therapeutic targets, antibodies, therapeutic compounds and drug candidates; scientific research relating to cell-surface proteins and antigens that are genomically amplified in cancer cells; scientific research relating to the targeted intracellular delivery of therapeutic agents to cancer cells; development of therapeutic platform technologies for the discovery and development of pharmaceuticals and therapeutic preparations; provision of scientific information and consultancy relating to pharmaceutical research, drug discovery and the development of therapeutic preparations; all of the aforesaid in the fields of cancer and oncology.
Econic Biosciences Limited
Representative: Potter Clarkson LLP